ArticleCancer medicine2022

Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.

Terry L Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.